Mycolactone in Blood of Buruli Ulcer Patients
Author Information
Author(s): Sarfo Fred S., Le Chevalier Fabien, Aka N'Guetta, Phillips Richard O., Amoako Yaw, Boneca Ivo G., Lenormand Pascal, Dosso Mireille, Wansbrough-Jones Mark, Veyron-Churlet Romain, Guenin-Macé Laure, Demangel Caroline
Primary Institution: Komfo Anokye Teaching Hospital, Kumasi, Ghana
Hypothesis
Does mycolactone diffuse from ulcerated lesions into the peripheral blood of Buruli ulcer patients and is it affected by antibiotic therapy?
Conclusion
Mycolactone can be detected in the serum and ulcer exudates of Buruli ulcer patients, suggesting its potential as a biomarker for diagnosis and monitoring treatment.
Supporting Evidence
- Mycolactone was found in ulcer exudates from all patients undergoing or completing antibiotic treatment.
- Mycolactone detection in serum may indicate a positive response to antibiotics.
- The study provides proof of concept for using mycolactone detection in diagnostic tests for Buruli ulcer.
Takeaway
Doctors found a substance called mycolactone in the blood of patients with a skin disease called Buruli ulcer, which could help them diagnose and treat the disease better.
Methodology
Patients' blood and ulcer exudates were sampled and analyzed for mycolactone using high performance liquid chromatography and mass spectrometry.
Limitations
The extraction method for mycolactone was not very effective, which may have led to underestimation of its presence.
Participant Demographics
Patients included both males and females, with a range of ages, and were recruited from Ghana and Ivory Coast.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website